Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer

NCT00005037 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: temozolomide
DRUG: Temozolomide

Sponsor

Fox Chase Cancer Center

Collaborators

[object Object]